Coty (COTY) Q4 2025 earnings review
Sales Plunge as Coty 'Cleans the Baseline'; Weak H1'26 Guidance Signals a Delayed Recovery
Coty's performance deteriorated sharply in Q4, with LFL sales falling 9%—an acceleration from the 3% decline in Q3. The weakness was broad-based but most severe in the Consumer Beauty division (-12% LFL), which saw its operating profitability collapse. Management attributed the poor results to a deliberate 'baseline reset' to clear excess retailer inventory ahead of a strong innovation cycle in FY26. However, this narrative is challenged by a weak outlook for the first half of FY26, which projects continued, albeit moderating, declines in both sales and profits. The recovery is now a back-half weighted story, dependent on the success of new launches in a challenging market.
🐂 Bull Case
Management is taking short-term pain to set up a cleaner start for FY26. If the issue is primarily retailer destocking, the company could see a sharp rebound once ordering aligns with sell-through.
The upcoming fiscal year is supported by major launches, including the new 'BOSS Bottled Beyond' which is reportedly tracking ahead of the highly successful 'Burberry Goddess' launch, and another blockbuster planned for H2'26.
🐻 Bear Case
The 9% LFL sales drop marks the fourth consecutive quarter of decelerating growth. A sales decline of this magnitude suggests issues beyond simple inventory management, pointing to potential weakness in consumer demand.
Guidance for continued sales and profit declines in H1'26 pushes any meaningful recovery out to mid-2026, increasing execution risk and testing investor patience.
⚖️ Verdict: 🔴
Bearish. The sharp and accelerating decline in sales and profitability is alarming. While management's 'baseline reset' narrative provides context, the weak guidance for the next two quarters suggests the problems are deeper than a one-time inventory flush. The recovery is now heavily reliant on perfect execution of future launches, making for a risky investment thesis in the near term.
Key Themes
Consumer Beauty Division in Crisis
The Consumer Beauty segment is the primary drag on performance, with LFL sales collapsing 12% in Q4. More concerningly, its adjusted EBITDA margin plummeted to 4.8% from 9.2% a year ago. Management cited weakness in mass color cosmetics and a strategic shift toward more profitable mass fragrances, but the severity of the decline raises questions about the health of cornerstone brands like CoverGirl and Rimmel.
U.S. Underperformance Drags Down Results
Management was candid that the U.S. market, representing nearly a quarter of sales, was the 'top driver for our underperformance.' LFL sales in the Americas fell 10% in Q4. The company has installed new leadership and a new regional structure to improve agility, but a turnaround in its largest market is critical and not yet visible in the results or guidance.
Recovery Narrative Contradicted by Weak Outlook
Management claims the Q4 sales plunge was a deliberate action to 'clean the baseline' for a strong FY26. However, guidance for a 6-8% LFL sales decline in Q1'26 and a 3-5% decline in Q2'26 contradicts the idea of a quick rebound. This suggests the headwinds from retailer caution and potential consumer demand weakness are more persistent than the narrative implies.
Major Push into Fragrance Mists
Coty is launching a significant, multi-brand attack on the fast-growing fragrance mist category, a $7 billion market. With launches planned across more than a dozen Prestige and Consumer Beauty brands, including recent rollouts for Calvin Klein and adidas, management believes this initiative can deliver returns equivalent to a fragrance blockbuster launch. This provides a new, specific avenue for growth.
Strong Innovation Pipeline for FY26
The core of the recovery story rests on a strong slate of new products. The recently launched 'BOSS Bottled Beyond' is reportedly tracking ahead of the FY24 blockbuster 'Burberry Goddess'. The company also plans another major blockbuster launch in the second half of FY26, alongside expansions for Marc Jacobs makeup (CY26) and the new Swarovski license (CY27).
Cost Savings to Buffer Margin Pressure
The ongoing 'All-in to Win' program provides a crucial financial cushion. The company expects to realize approximately $80 million in fixed cost savings and $120 million in productivity savings in FY26. These savings will help offset the impact of lower sales volumes, tariff headwinds, and the resumption of variable compensation in H1'26.
Navigating Tariffs and a Cautious Macro Environment
The company is bracing for a complex FY26, citing cautious retailer ordering, a promotional competitive environment, and a gross tariff headwind of approximately $70 million. Mitigation plans are in place, including shifting some fragrance production to the U.S. and implementing price increases, but these external pressures will weigh on H1'26 results.
Other KPIs
Reversing. After three quarters of flat to positive YoY growth, Q4 Adjusted EBITDA fell 23% to $126.7 million, dragging the full-year result to a 1% decline. The outlook for H1'26 is for continued double-digit declines, highlighting severe near-term profit pressure.
FY25 free cash flow came in below the company's target of around $300 million, impacted by lower cash profits and higher customer overdues. However, management provided a seasonally strong forecast for H1'26 of over $350 million.
Leverage ticked up from 3.2x in Q3 due to the sharp drop in Q4 EBITDA. While this is a near-term negative, the ratio is down significantly from 6.8x in FY21, and deleveraging remains a key long-term priority.
Guidance
Decelerating. This guidance implies a continued, though sequentially improving, sales decline. The midpoint of Q1 guidance (-7%) is an improvement from Q4's -9% but represents a sharp drop from the +4% growth seen in Q1'25. The outlook confirms the 'cleanup' extends well beyond Q4.
Reversing. This guidance signals a significant profit downturn compared to H1'25, where Adj. EBITDA grew. The decline is driven by negative operating leverage from lower sales, gross margin pressure from tariffs, and the reinstatement of variable compensation.
Management expects both LFL sales and adjusted EBITDA to return to growth in the second half of the fiscal year. This forecast relies on the success of new launches, easing prior-year comparisons, and the benefits of cost-saving and tariff-mitigation programs.
Key Questions
Consumer Beauty Profitability Floor
Your Consumer Beauty adjusted EBITDA margin fell to 4.8% in Q4. Beyond shifting focus to mass fragrances, what specific, immediate actions are you taking to stabilize profitability in the core color cosmetics business, and should we expect this segment to be a drag on consolidated margins through H1'26?
H2'26 Growth Confidence
The recovery narrative is heavily weighted to H2'26. What gives you confidence you can achieve both sales and EBITDA growth in H2, given the steep declines guided for H1 and the current promotional environment? What are the key milestones we should watch for in Q1 and Q2 to track this recovery?
U.S. Market Turnaround
Management cited U.S. underperformance as the primary driver of declines. With new leadership in place, what are the top 2-3 operational changes being made, and when do you expect to see Coty's U.S. sell-through begin to consistently outperform the market again?